Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-18 · accession 0000950170-24-129227 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-20 | 2024-11-18 | IRWD | Emany Sravan Kumar | SVP, COO, CFO | S - Sale | $4.08 | -11.0K | 309.6K | -3% | -$44.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-18 | S | D | 11,001 | $4.08 | 309,572 | D | — | — |